These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36608495)
1. The effect of the Flemish breast cancer screening program on breast cancer-specific mortality: A case-referent study. De Troeyer K; Silversmit G; Rosskamp M; Truyen I; Van Herck K; Goossens MM; Martens P; Kellen E; Hendrickx E; Rummens E; De Smet F; Broeders M; Verdoodt F; De Schutter H Cancer Epidemiol; 2023 Feb; 82():102320. PubMed ID: 36608495 [TBL] [Abstract][Full Text] [Related]
2. Mammography screening: A major issue in medicine. Autier P; Boniol M Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783 [TBL] [Abstract][Full Text] [Related]
3. Increasingly strong reduction in breast cancer mortality due to screening. van Schoor G; Moss SM; Otten JD; Donders R; Paap E; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL Br J Cancer; 2011 Mar; 104(6):910-4. PubMed ID: 21343930 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer screening halves the risk of breast cancer death: a case-referent study. Paap E; Verbeek AL; Botterweck AA; van Doorne-Nagtegaal HJ; Imhof-Tas M; de Koning HJ; Otto SJ; de Munck L; van der Steen A; Holland R; den Heeten GJ; Broeders MJ Breast; 2014 Aug; 23(4):439-44. PubMed ID: 24713277 [TBL] [Abstract][Full Text] [Related]
5. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011. Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141 [TBL] [Abstract][Full Text] [Related]
6. Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016). Goossens M; De Brabander I; De Grève J; Van Ongeval C; Martens P; Van Limbergen E; Kellen E BMC Cancer; 2019 Oct; 19(1):1012. PubMed ID: 31660890 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer screening effectiveness in Portugal central Region. Bastos J; Rodrigues V; Paap E; Broeders M; Pina M; Cruz D; Carrito B; António Silva M Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S204-S207. PubMed ID: 28574867 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands. van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083 [TBL] [Abstract][Full Text] [Related]
10. Pan-Canadian study of mammography screening and mortality from breast cancer. Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578 [TBL] [Abstract][Full Text] [Related]
11. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. Coldman A; Phillips N CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101 [TBL] [Abstract][Full Text] [Related]
12. Benefits and harms of mammography screening. Løberg M; Lousdal ML; Bretthauer M; Kalager M Breast Cancer Res; 2015 May; 17(1):63. PubMed ID: 25928287 [TBL] [Abstract][Full Text] [Related]
13. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study. Morrell S; Taylor R; Roder D; Dobson A J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322 [TBL] [Abstract][Full Text] [Related]
14. Mammography screening and risk of breast cancer death: a population-based case-control study. Otto SJ; Fracheboud J; Verbeek AL; Boer R; Reijerink-Verheij JC; Otten JD; Broeders MJ; de Koning HJ; Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):66-73. PubMed ID: 22147362 [TBL] [Abstract][Full Text] [Related]
15. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Nelson HD; Tyne K; Naik A; Bougatsos C; Chan BK; Humphrey L; Ann Intern Med; 2009 Nov; 151(10):727-37, W237-42. PubMed ID: 19920273 [TBL] [Abstract][Full Text] [Related]
16. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up. Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679 [TBL] [Abstract][Full Text] [Related]
17. Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial. van der Waal D; Broeders MJ; Verbeek AL; Duffy SW; Moss SM Epidemiology; 2015 Jul; 26(4):590-6. PubMed ID: 25767987 [TBL] [Abstract][Full Text] [Related]
18. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Johns LE; Coleman DA; Swerdlow AJ; Moss SM Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047 [TBL] [Abstract][Full Text] [Related]
19. Uptake of cancer screening among adults with disabilities in Flanders (Belgium). Kellen E; Nuyens C; Molleman C; Hoeck S J Med Screen; 2020 Mar; 27(1):48-51. PubMed ID: 31474187 [TBL] [Abstract][Full Text] [Related]